Logo image
Paradoxical severe agitation induced by add-on high-doses quetiapine in schizo-affective disorder
Article de revue scientifique   Avec comité de lecture

Paradoxical severe agitation induced by add-on high-doses quetiapine in schizo-affective disorder

Guillaume Fond, Alexandra MacGregor, Deborah Ducasse et Marie Brittner
Psychiatry research, Vol.216(2), p.286-287
15/05/2014
PMID: 24582773

Résumé

Adult Aggression - drug effects Antipsychotic Agents - administration & dosage Antipsychotic Agents - adverse effects Antipsychotic Agents - therapeutic use Dibenzothiazepines - administration & dosage Dibenzothiazepines - adverse effects Dibenzothiazepines - therapeutic use Dyskinesia, Drug-Induced Humans Male Psychomotor Agitation - physiopathology Psychotic Disorders - drug therapy Psychotic Disorders - physiopathology Psychotic Disorders - psychology Quetiapine Fumarate
We report the case of a 35-year-old patient suffering from schizo-affective disorder since the age of 19 years, treated by a combination of first-generation antipsychotics, zuclopenthixol (100 mg/day) and lithium (1200 mg/day) (serum lithium=0.85 mEq/l). This patient had no associated personality disorder (particularly no antisocial disorder) and no substance abuse disorder. Within the 48 h following the gradual introduction of quetiapine (up to 600 mg/day), the patient presented severe agitation without an environmental explanation, contrasting with the absence of a history of aggressiveness or personality disorder. The diagnoses of manic shift and akathisia were dismissed. The withdrawal and the gradual reintroduction of quetiapine 2 weeks later, which led to another severe agitation, enabled us to attribute the agitation specifically to quetiapine.

Indicateurs

1 Consultations de la notice

Détails

Logo image